Triumph Capital Management’s Hologic HOLX Stock Holding History

Triumph Capital Management’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-9	Closed	-$680	–	1886
2026 Q1	$680	Hold	9	–	–	﹤0.01%	1670
2025 Q4	$670	Buy	+9	New	+$658	﹤0.01%	1618

Other funds holding HOLX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Triumph Capital Management's HOLX Position: Q2 2026 in Review

Triumph Capital Management sold out of Hologic (HOLX) in Q2 2026, closing a stake of 9 shares — an estimated $680 sold.

Triumph Capital Management first reported a position in HOLX in Q4 2025 and held it in 2 quarters. The position peaked at $680 in Q1 2026. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

Triumph Capital Management reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
Triumph Capital Management sold 9 Hologic shares in Q2 2026, an estimated $680.
Triumph Capital Management first reported a position in Hologic in Q4 2025 and held it in 2 quarters.
Triumph Capital Management's Hologic position peaked at $680 in Q1 2026.
3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Triumph Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.